Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Joshua Daniel Rosenblat, M. Ishrat Husain
Abstract
Authors
Institutions
Provenance
crossref
No local reference links have been materialized yet.
Adverse events in studies of classic psychedelics: a systematic review and meta-analysis.
10.1001/jamapsychiatry.2024.2546 · 2024
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force report: serotonergic psychedelic treatments for major depressive disorder.
10.1177/07067437221111371 · 2023
Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial.
10.1001/jama.2023.14530 · 2023
Single-dose psilocybin for a treatment-resistant episode of major depression.
10.1056/nejmoa2206443 · 2022
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: a living systematic review with meta-analysis.
10.1016/j.euroneuro.2025.09.011 · 2025
Psilocybin or nicotine patch for smoking cessation: a pilot randomized clinical trial.
10.1001/jamanetworkopen.2026.0972 · 2026
Acute adverse effects of therapeutic doses of psilocybin: a systematic review and meta-analysis.
10.1001/jamanetworkopen.2024.5960 · 2024
Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.
10.1177/20451253251372449 · 2025
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Blinding integrity in psychedelic randomized clinical trials: a systematic review.
10.1001/jamapsychiatry.2026.0255 · 2026
Psychological therapy quantity and depressive symptom reduction in psychedelic-assisted therapy: a systematic review and meta-analysis.
10.1001/jamanetworkopen.2025.54843 · 2026
No additional external references are available.